News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
NeoStem, Inc.'s Stem Cell Therapy Fails Mid-Stage Heart Attack Study     11/19/2014
Cynapsus Therapeutics (CYNAF) Announces Positive Top-Line Results From CTH-105 Phase 2 Study Of APL-130277 For The Treatment Of OFF Episodes In Patients With Parkinson's Disease     11/19/2014
Merck & Co. (MRK) Announces Positive Study Investigating The Use Of KEYTRUDA® (pembrolizumab) Compared To Chemotherapy In Patients With Ipilimumab-Refractory Advanced Melanoma     11/17/2014
Puma Biotechnology (PBYI)'s Cancer Drug Neratinib Fails Mid-Stage Study     11/14/2014
Alnylam Pharmaceuticals (ALNY) Reports Positive Initial Phase 2 Data With Revusiran     11/14/2014
Chimerix, Inc. (CMRX)'s Brincidofovir Antiviral To Be Tested In West African Ebola Trial     11/14/2014
AbbVie (ABBV)'s Hepatitis C Drug Cures 97 Percent In Phase 2 Transplant Patients Study     11/13/2014
Regeneron (REGN), Sanofi (SAN.PA)'s Dual-Action Biotech Asthma Drug Performs Well In Key Test     11/12/2014
Merck & Co. (MRK)'s Four-Week Hep C Regimen With Gilead Sciences, Inc. (GILD)'s Sovaldi Fails To Deliver     11/11/2014
ArQule, Inc. (ARQL) Reports Positive Phase 2 Tivantinib Prostate Cancer Trial Data     11/10/2014
Intercept Pharmaceuticals (ICPT) Tanks As Liver Drug Needs Safety Review: Investigators     11/10/2014
Omeros Corporation (OMER) Announces Positive Data for MASP-2 Inhibitor In Experimental Model Of Stroke     11/6/2014
Exelixis, Inc. (EXEL) Reports Top-Line Results From A Phase 2 Trial Of Cabozantinib     11/5/2014
Merck & Co. (MRK) Reports Positive Data From Phase 2b Doravirine Trial     11/4/2014
Bristol-Myers Squibb Company (BMY)'s Opdivo Wows In Phase 2 Lung Cancer Study     10/31/2014

Featured Stories
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study     12/30/2010
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial     12/13/2010
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study     12/7/2010
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study     11/11/2010
American Association for Study of Liver Diseases: Early Study Shows HCV Vaccine Works, Scripps Clinic Study     11/3/2010
American Association for Study of Liver Diseases: Rapid Response for Once-Daily Protease Inhibitor, University of North Carolina Study     11/3/2010
American Academy of Ophthalmology: Glaucoma Drug Passes Early Clinical Test     10/21/2010
Ceregene, Inc. Initiates a New Controlled Phase 2b Trial of Cere-120 for Parkinson's Disease     10/19/2010
American Society for Bone and Mineral Research: Novel Drug Promising in Osteoporosis, University of Erlangen Study Reveals     10/19/2010
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression     10/19/2010
Immunomedics, Inc. (IMMU) Announces Orphan Drug Designation For Veltuzumab For The Treatment Of Pemphigus     11/21/2014
Xenetic Biosciences Partner Completes First Patient Cohort In Phase 2 Study With MyeloXen™ For Multiple Sclerosis     11/21/2014
ChemoCentryx, Inc. (CCXI)'s CCX168, An Orally Administered Complement C5a Receptor Inhibitor, Granted Orphan-Drug Designation In Atypical Hemolytic Uremic Syndrome Treatment By The FDA     11/21/2014
University of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy     11/21/2014
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Final Analysis Of The Phase II Clinical Study On Elafin In Coronary Artery Bypass Surgery Completed     11/21/2014
Clementia Pharmaceuticals Receives European Medicines Agency Orphan Medicinal Product Designation For Palovarotene For The Treatment Of Fibrodysplasia Ossificans Progressiva     11/21/2014
Intra-Cellular Therapies, Inc. Announces Additional Results From Phase I/2 Clinical Trial For ITI-007 In Healthy Geriatric Subjects And Patients With Dementia     11/21/2014
NeoStem, Inc. Provides Further Information Regarding The Design Of The Phase 2 PreSERVE AMI Clinical Trial     11/21/2014
BioSpecifics Technologies Corporation (BSTC) Announces New Data On XIAFLEX For Peyronie's Disease Presented At SMSNA Scientific Meeting     11/21/2014
Clovis Oncology (CLVS) Release: Initial Data From Ongoing Phase 2 ARIEL2 Study Of Rucaparib In Ovarian Cancer Demonstrate Encouraging Clinical Activity And Safety In Both BRCA Mutant And Brcaness Patients     11/20/2014
Neurotrope Announces Last Patient Dosed In Phase 2a Clinical Trial Of Bryostatin-1 For Alzheimer's Disease     11/20/2014
Transition Therapeutics Inc. (TTH.TO) Announces Results From ELND005 Clinical Study In Adults With Down Syndrome     11/20/2014
St. Jude Children's Research Hospital Release: Gene Therapy Provides Safe, Long-Term Relief For Patients With Severe Hemophilia B     11/20/2014
DBV Technologies Initiates Phase I/2 Clinical Trial With Viaskin Milk For The Treatment Of Children With Cow's Milk Allergy     11/20/2014
PRANA Biotechnology (PRAN) Release: The Lancet Neurology Publishes Prana's Huntington Disease Trial     11/20/2014

More News
No News Posted on that date

Career Tips
Ardea Biosciences, Inc. HR VP Shares A Fool-Proof Guide To Joining A Startup     11/20/2014
3 Signs Your Resume Isn't Working     11/20/2014
3 Deadly Mistakes Made In Job Interviews     11/20/2014
4 Essentials Of A Good Cover Letter     11/20/2014
Sanofi (SAN.PA) And Incyte Corporation (INCY) Execs Exclusive: Future Hiring Trends And What They're Looking For In New Hires     11/7/2014
4 Common Mistakes That Sabotage Your Resume     11/6/2014
3 Tips To Capture The Hiring Manager's Interest In Seconds     11/6/2014
10 Shocking Job Search Blunders     11/6/2014
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/27/2014
Get The Inside Track: Hiring Tips From An Eli Lilly (LLY) HR Exec     10/23/2014
5 Bad Interview Answers To Avoid     10/23/2014
What Separates Good Resumes From Bad Resumes?     10/23/2014
6 Out-Of-The-Box Job Search Ideas That Worked     10/23/2014
Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond     10/17/2014
Biotech’s Biggest Hirers Of The Last 5 Years     10/13/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->